自我指压治疗过敏性鼻炎的可行性:一项预试验随机对照试验及未来研究经验
结果显示指压可行且未见重大不良事件,但两组在症状 severity、生活质量及用药方面无统计学显著差异,特异性指压组患者认为指压有用并推荐自我护理。结论认为自我指压可行且似安全,需大规模随机对照试验进一步验证疗效与安全性。
要点
- 自我指压治疗过敏性鼻炎可行且未见重大不良事件。
- 特异性与非特异性指压组在症状、生活质量及用药上无显著差异。
- 特异性指压组患者认为指压有用并推荐用于自我护理。
核心结论
- 指压可由过敏性鼻炎患者自我实施,可行且似安全。
- 预试验未发现特异性指压优于非特异性指压的统计学显著差异。
- 需大规模随机对照试验进一步验证自我指压治疗过敏性鼻炎的疗效与安全性。
研究设计与样本
- 随机、单盲、非特异性对照临床试验,在澳大利亚墨尔本皇家墨尔本理工大学开展。
- 干预为每穴1分钟、每日两次,治疗4周,随访8周。
- 主要结局为7点量表症状严重程度变化,次要结局包括鼻结膜炎生活质量问卷、用药、不良事件及盲法可信度。
主要发现
- 特异性指压组与非特异性指压组在7点量表症状严重程度评分、鼻结膜炎生活质量问卷或用药方面均无统计学显著差异。
- 特异性指压组参与者认为指压对过敏性鼻炎有用并推荐用于自我护理。
- 盲法可信度成功,未发现与干预相关的不良反应。
临床怎么用
- 可将自我指压作为过敏性鼻炎患者可行的自我护理选项之一。
- 目前证据尚不足以推荐特异性指压优于非特异性指压。
- 临床实施时需关注不良事件,并告知患者疗效证据有限。
局限性
- 未报告效应量、置信区间或P值等详细统计结果。
- 随访8周,长期疗效与安全性未确定。
- 需大规模随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Allergic rhinitis (AR) is an immunoglobulin (Ig)E-mediated inflammatory condition that is highly prevalent worldwide. The aim of this pilot trial was to evaluate the feasibility and safety of self-administered acupressure for AR. METHODS: A randomized, single-blind, non-specific controlled clinical trial was conducted at Royal Melbourne Institute of Technology (RMIT) University, Melbourne, Australia. Fifteen AR patients were randomized into two groups: self-administered acupressure at five specific acupressure (SA) points or five non-specific acupressure (NSA) points (1 min/point, twice a day), and treated for 4 weeks with an 8-week follow-up period. The primary outcome was the change in 7-point scale symptom severity. Secondary outcomes included the rhinoconjunctivitis quality of life questionnaire and standardized activities (RQLQs), medication usage, adverse events and participants' opinions of the blinding method. The Statistical Package for the Social Science (SPSS) version 26 was used for data analyses. RESULTS: Fourteen participants completed the study and no major adverse events were reported. No statistically significant differences between SA and NSA groups were identified in 7-point scale symptom severity scores, RQLQs or medication usage. However, participants in the SA group believed that SA was useful for AR and recommended it for self-care. The credibility of the blinding method was successful. No adverse effects were considered to be related to the intervention. CONCLUSION: Acupressure is feasible and appears to be safe for self-administration by AR sufferers. Experience from this pilot study has guided minor amendments to the protocol. A large-scale randomized controlled trial is warranted to further investigate the efficacy and safety of self-administered acupressure for the management of AR.
引用
- Liang Y, Lenon GB, Li M, et al. Feasibility of self-administered acupressure for allergic rhinitis: a pilot randomized controlled trial and lessons learnt for future studies. Acupunct Med. 2021. PMID: 34763534. doi:10.1177/09645284211055757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。